Related references
Note: Only part of the references are listed.Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy
Taraprasad Das et al.
SCIENTIFIC REPORTS (2021)
In Situ Biomanufacturing of Small Molecules in the Mammalian Gut by Probiotic Saccharomyces boulardii
Deniz Durmusoglu et al.
ACS SYNTHETIC BIOLOGY (2021)
Shared and distinctive features of the gut microbiome of C57BL/6 mice from different vendors and production sites, and in response to a new vivarium
Lauren L. Long et al.
LAB ANIMAL (2021)
The Microbiota-Gut-Brain Axis in Health and Disease and Its Implications for Translational Research
Melanie Anna Schaechtle et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Predictable modulation of cancer treatment outcomes by the gut microbiota
Yoshitaro Heshiki et al.
MICROBIOME (2020)
Treatment of murine colitis bySaccharomyces boulardiisecreting atrial natriuretic peptide
Cheng-Hao Liu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria
Bastian Seelbinder et al.
MICROBIOME (2020)
Comparison of different modes of antibiotic delivery on gut microbiota depletion efficiency and body composition in mouse
Pauline Tirelle et al.
BMC MICROBIOLOGY (2020)
A probiotic yeast-based immunotherapy against Clostridioides difficile infection
Kevin Chen et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital
Brigida Barberio et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
A systematic review on different models of inducing obesity in animals: Advantages and limitations
Joseph Bagi Suleiman et al.
JOURNAL OF ADVANCED VETERINARY AND ANIMAL RESEARCH (2020)
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
Joao B. Xavier et al.
TRENDS IN CANCER (2020)
An engineered E-coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
Caroline B. Kurtz et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox
Danielle B. Pedrolli et al.
TRENDS IN BIOTECHNOLOGY (2019)
Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor-/- Mice Improves Indices of Cardiometabolic Disease
Linda S. May-Zhang et al.
SCIENTIFIC REPORTS (2019)
Host genetic variation and its microbiome interactions within the Human Microbiome Project
Raivo Kolde et al.
GENOME MEDICINE (2018)
Oral Administration of Recombinant Saccharomyces boulardii Expressing Ovalbumin-CPE Fusion Protein Induces Antibody Response in Mice
Ghasem Bagherpour et al.
FRONTIERS IN MICROBIOLOGY (2018)
Probiotics in Disease Prevention and Treatment
Yuying Liu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
Vincent M. Isabella et al.
NATURE BIOTECHNOLOGY (2018)
Assessing and Interpreting the Within-Body Biogeography of Human Microbiome Diversity
Zhanshan Ma et al.
FRONTIERS IN MICROBIOLOGY (2018)
Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria
Elizabeth A. Kennedy et al.
FRONTIERS IN PHYSIOLOGY (2018)
Microbiota and reproducibility of rodent models
Craig L. Franklin et al.
LAB ANIMAL (2017)
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
Paul W. O'Toole et al.
NATURE MICROBIOLOGY (2017)
Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii
Indu Khatri et al.
SCIENTIFIC REPORTS (2017)
Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis
S. P. Costello et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization
Hana Kozakova et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Microbiome therapeutics - Advances and challenges
Mark Mimee et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Metabolic Engineering of Probiotic Saccharomyces boulardii
Jing-Jing Liu et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2016)
Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System
Lauren E. Hudson et al.
PLOS ONE (2016)
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender et al.
PLOS BIOLOGY (2016)
Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design
Debby Laukens et al.
FEMS MICROBIOLOGY REVIEWS (2016)
Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling
Maayan Levy et al.
CELL (2015)
Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes
Franklin F. Duan et al.
DIABETES (2015)
Escherichia coli EDL933 Requires Gluconeogenic Nutrients To Successfully Colonize the Intestines of Streptomycin-Treated Mice Precolonized with E-coli Nissle 1917
Silvia A. C. Schinner et al.
INFECTION AND IMMUNITY (2015)
Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice
Sofie Robert et al.
DIABETES (2014)
Oral Delivery of Glucagon Like Peptide-1 by a Recombinant Lactococcus lactis
Payal Agarwal et al.
PHARMACEUTICAL RESEARCH (2014)
Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii
Lauren E. Hudson et al.
PLOS ONE (2014)
Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice
Amandine Everard et al.
MBIO (2014)
Estimation of fungal biomass in forest litter and soil
Petr Baldrian et al.
FUNGAL ECOLOGY (2013)
Quantitative Phenotyping of Inflammatory Bowel Disease in the IL-10-deficient Mouse by Use of Noninvasive Magnetic Resonance Imaging
Svenja Michael et al.
INFLAMMATORY BOWEL DISEASES (2013)
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ
Caitriona M. Guinane et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
Tatiana Takiishi et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders
Theodoros Kelesidis et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2012)
Extraction of genomic DNA from yeasts for PCR-based applications
Marko Looke et al.
BIOTECHNIQUES (2011)
Quantifying microbial communities with 454 pyrosequencing: does read abundance count?
Anthony S. Amend et al.
MOLECULAR ECOLOGY (2010)
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
Lynne V. McFarland
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Prolonged Impact of Antibiotics on Intestinal Microbial Ecology and Susceptibility to Enteric Salmonella Infection
Amy Croswell et al.
INFECTION AND IMMUNITY (2009)
Enzymatic assembly of DNA molecules up to several hundred kilobases
Daniel G. Gibson et al.
NATURE METHODS (2009)
Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiaev
Laura Edwards-Ingram et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes
Guillaume Dalmasso et al.
GASTROENTEROLOGY (2006)
Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii
JLR Fietto et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2004)
rrndb: the Ribosomal RNA Operon Copy Number Database
JA Klappenbach et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
